| 000 | 01768 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517211823.0 | ||
| 264 | 0 | _c20181227 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1464-3405 | ||
| 024 | 7 |
_a10.1016/j.bmcl.2018.04.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAgarwal, Sameer | |
| 245 | 0 | 0 |
_aEvaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _c06 2018 |
||
| 300 |
_a1849-1852 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xmetabolism |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xchemistry |
| 650 | 0 | 4 |
_aImidazoles _xchemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xagonists |
| 650 | 0 | 4 |
_aSitagliptin Phosphate _xtherapeutic use |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aSasane, Santosh | |
| 700 | 1 | _aKumar, Jeevan | |
| 700 | 1 | _aDeshmukh, Prashant | |
| 700 | 1 | _aBhayani, Hitesh | |
| 700 | 1 | _aGiri, Poonam | |
| 700 | 1 | _aGiri, Suresh | |
| 700 | 1 | _aSoman, Shubhangi | |
| 700 | 1 | _aKulkarni, Neelima | |
| 700 | 1 | _aJain, Mukul | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 28 _gno. 10 _gp. 1849-1852 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2018.04.011 _zAvailable from publisher's website |
| 999 |
_c28287958 _d28287958 |
||